Beta blockers amlodipine
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
The Combined Use of Beta Blockers and Amlodipine in Cardiovascular Treatment
Introduction to Beta Blockers and Amlodipine
Beta blockers and amlodipine are commonly used medications in the management of cardiovascular conditions such as hypertension and angina. Beta blockers work by reducing heart rate and the force of heart contractions, while amlodipine, a calcium channel blocker, relaxes blood vessels, improving blood flow and reducing blood pressure. This article synthesizes research on the combined use of these medications to provide a comprehensive understanding of their efficacy and safety.
Efficacy in Reducing Ischemic Episodes
Beta Blockers and Amlodipine in Coronary Artery Disease
Research has shown that beta blockers are effective in reducing the frequency and duration of ischemic episodes in patients with coronary artery disease. However, the addition of amlodipine to beta blocker therapy has been investigated to determine if it offers additional benefits. A study involving 313 patients with documented coronary artery disease found that adding amlodipine did not significantly reduce the frequency or duration of ambulatory ischemia compared to placebo. This suggests that while beta blockers are effective, the addition of amlodipine may not provide further anti-ischemic benefits in such patients.
Combination Therapy in Hypertension
In patients with hypertension, combining beta blockers with amlodipine has shown promising results. A study involving hypertensive patients treated with bisoprolol (a beta blocker) and amlodipine demonstrated significant reductions in both central and brachial systolic blood pressure (SBP) and pulse pressure (PP). This combination therapy effectively eliminated the adverse effect of beta blockers on aortic pulse pressure augmentation, leading to better blood pressure control.
Impact on Angina and Exercise Capacity
Chronic Stable Angina
For patients with chronic stable angina, the addition of amlodipine to beta blocker therapy has been shown to improve exercise capacity and reduce angina symptoms. In a multicenter, placebo-controlled study, patients receiving amlodipine experienced significant increases in exercise time and total work accomplished compared to those on placebo. Another study confirmed these findings, showing that amlodipine increased exercise time to angina onset and reduced angina attack frequency and nitroglycerin consumption when added to beta blocker therapy.
Long-Term Benefits
Long-term studies have also highlighted the benefits of amlodipine in combination with beta blockers. Over a one-year period, patients treated with amlodipine showed improved resistance artery structure and endothelial function compared to those treated with atenolol (a beta blocker). This vascular protective effect suggests that amlodipine may offer additional long-term benefits beyond blood pressure control.
Cardiovascular Event Prevention
Comparative Studies
The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT-BPLA) compared the effects of an amlodipine-based regimen with an atenolol-based regimen in preventing cardiovascular events. The study found that the amlodipine-based regimen was more effective in reducing total cardiovascular events, stroke, and all-cause mortality compared to the atenolol-based regimen. Additionally, the amlodipine-based regimen was associated with a lower incidence of developing diabetes.
Blood Pressure Variability and Stroke Risk
Further analysis of the ASCOT-BPLA trial revealed that amlodipine reduced blood pressure variability more effectively than atenolol, which partly explained the lower risk of stroke observed in the amlodipine group. This finding underscores the importance of considering blood pressure variability in addition to mean blood pressure in the management of hypertension.
Conclusion
The combination of beta blockers and amlodipine offers significant benefits in the management of hypertension and angina. While beta blockers alone are effective in reducing ischemic episodes, the addition of amlodipine can improve exercise capacity, reduce angina symptoms, and provide long-term vascular protection. Moreover, amlodipine-based regimens have been shown to prevent more cardiovascular events and reduce blood pressure variability, which is crucial in minimizing stroke risk. These findings highlight the potential advantages of combining these two classes of medications in cardiovascular treatment.
Sources and full results
Most relevant research papers on this topic